Prevention of SARS-CoV-2 infection through development and clinical testing of a novel Virus Like Particle (VLP) vaccine

Projektbeschreibung

A novel vaccine against the SARS-CoV-2 virus

There is an ongoing race towards the development of a vaccine against the SARS-CoV-2 virus. The EU-funded Prevent-nCoV project will use proprietary technology to develop a novel and scalable vaccine with proven efficacy in an animal model. The technology uniquely combines virus-like particles (VLP) and the antigen of choice produced by any expression system. The two components are mixed under physiological conditions, leading to the high-density display of the antigen on the VLP surface. Vaccine candidates will initially be tested for their virus neutralisation capacity in vitro and in preclinical infection models before proceeding with a phase I/IIa study.

Wissenschaftliches Gebiet

• /Medizin- und Gesundheitswissenschaften/Gesundheitswissenschaften/Infektionskrankheit/RNA-Virus/Coronavirus

Programm/Programme

• H2020-EU.3.1.3. - Treating and managing disease

Thema/Themen

• SC1-PHE-CORONAVIRUS-2020 - Advancing knowledge for the clinical and public health response to the 2019-nCoV epidemic

Aufforderung zur Vorschlagseinreichung

H2020-SC1-PHE-CORONAVIRUS-2020
Andere Projekte für diesen Aufruf anzeigen

Finanzierungsplan

RIA - Research and Innovation action

Koordinator

KOBENHAVNS UNIVERSITET

Adresse

Norregade 10
1165 Kobenhavn
Dänemark

Aktivitätstyp

Higher or Secondary Education Establishments

EU-Beitrag

€ 128 647,50

Beteiligte (5)

ADAPTVAC APS

Dänemark

EU-Beitrag

€ 781 250

Adresse

Agern Alle 1
2970 Horsholm

Aktivitätstyp

Private for-profit entities (excluding Higher or Secondary Education Establishments)

EBERHARD KARLS UNIVERSITAET TUEBINGEN

Deutschland

EU-Beitrag

€ 840 787,50

Adresse

Geschwister-scholl-platz
72074 Tuebingen

Aktivitätstyp

Higher or Secondary Education Establishments

EXPRES2ION BIOTECHNOLOGIES APS

Dänemark

EU-Beitrag

€ 860 882,50

Adresse

Agern Alle 1
2970 Horsholm

Aktivitätstyp

Private for-profit entities (excluding Higher or Secondary Education Establishments)

WAGENINGEN UNIVERSITY

Niederlande

EU-Beitrag

€ 66 147,50

Adresse

Droevendaalsesteeg 4
6708 PB Wageningen

Aktivitätstyp

Higher or Secondary Education Establishments

ACADEMISCH ZIEKENHUIS LEIDEN

Niederlande

EU-Beitrag

€ 50 625

Adresse

Albinusdreef 2
2333 ZA Leiden

Aktivitätstyp

Higher or Secondary Education Establishments